Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae207 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Debodipta Das und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hispanic or Latino, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
The incidence and mortality rates of hepatocellular carcinoma among Hispanic individuals in the United States are much higher than in non-Hispanic White people. We conducted multi-omics analyses to elucidate molecular alterations in hepatocellular carcinoma among Hispanic patients.
Methods
Paired tumor and adjacent nontumor samples were collected from 31 Hispanic hepatocellular carcinomas in South Texas for genomic, transcriptomic, proteomic, and metabolomic profiling. Serum lipids were profiled in 40 Hispanic and non-Hispanic patients with or without clinically diagnosed hepatocellular carcinoma.
Results
Exome sequencing revealed high mutation frequencies of AXIN2 and CTNNB1 in South Texas Hispanic hepatocellular carcinoma patients, suggesting a predominant activation of the Wnt/β-catenin pathway. TERT promoter mutations were also statistically significantly more frequent in the Hispanic cohort (Fisher exact test, P < .05). Cell cycles and liver function were positively and negatively enriched, respectively, with gene set enrichment analysis. Gene sets representing specific liver metabolic pathways were associated with dysregulation of corresponding metabolites. Negative enrichment of liver adipogenesis and lipid metabolism corroborated with a significant reduction in most lipids in serum samples of hepatocellular carcinoma patients (paired t test, P < .0001). Two hepatocellular carcinoma subtypes from our Hispanic cohort were identified and validated with the Cancer Genome Atlas liver cancer cohort. Patients with better overall survival showed higher activity of immune and angiogenesis signatures and lower activity of liver function–related gene signatures. They also had higher levels of immune checkpoint and immune exhaustion markers.
Conclusions
Our study revealed specific molecular features of Hispanic hepatocellular carcinoma and potential biomarkers for therapeutic management. It provides a unique resource for studying Hispanic hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
- Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
- Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
- Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
- Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
- Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
ORCID-Profile: Yu-Chiao Chiu, Xiang Gu, Matyas Cserhati, Lu-Zhe Sun
Förderung
- NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- Cancer Prevention & Research Institute of Texas
- Shared Resources of Mays Cancer Center's Next Generation Sequencing
- NIH
- Clayton Foundation for Research
- University of Texas System Proteomics Core Network
Zitieren
APA
Das, D., Wang, X., Chiu, Y. C., Bouamar, H., Sharkey, F. E., Lopera, J. E., Lai, Z., Weintraub, S. T., Han, X., Zou, Y., Chen, H. H., Zeballos Torrez, C. R., Gu, X., Cserhati, M., Michalek, J. E., Halff, G. A., Chen, Y., Zheng, S., Cigarroa, F. G., & Sun, L. Z. (2024). Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae207
Vancouver
Das D, Wang X, Chiu YC, Bouamar H, Sharkey FE, Lopera JE, et al. Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae207
BibTeX
@article{Das2024,
author = {Das, Debodipta and Wang, Xiaojing and Chiu, Yu-Chiao and Bouamar, Hakim and Sharkey, Francis E and Lopera, Jorge E and Lai, Zhao and Weintraub, Susan T and Han, Xianlin and Zou, Yi and Chen, Hung-I H and Zeballos Torrez, Carla R and Gu, Xiang and Cserhati, Matyas and Michalek, Joel E and Halff, Glenn A and Chen, Yidong and Zheng, Siyuan and Cigarroa, Francisco G and Sun, Lu-Zhe},
title = {Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae207}
}
EUVIMED